Dalal AA - Search Results

1

Adherence to controller therapy for chronic obstructive pulmonary disease: a review.

Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Charles MS, et al. Among authors: dalal aa. Curr Med Res Opin. 2010 Oct;26(10):2421-9. doi: 10.1185/03007995.2010.516284. Curr Med Res Opin. 2010. PMID: 20815661 Review.

2

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM. Delea TE, et al. Among authors: dalal aa. Curr Med Res Opin. 2009 Jan;25(1):1-13. doi: 10.1185/03007990802534020. Curr Med Res Opin. 2009. PMID: 19210134

3

Cost and utilization of COPD and asthma among insured adults in the US.

Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Blanchette CM, et al. Among authors: dalal aa. Curr Med Res Opin. 2009 Jun;25(6):1385-92. doi: 10.1185/03007990902875927. Curr Med Res Opin. 2009. PMID: 19419342

4

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA. Simoni-Wastila L, et al. Among authors: dalal aa. Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157. Curr Med Res Opin. 2009. PMID: 19778165

5

Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.

Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Blanchette CM, et al. Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005. Am J Geriatr Pharmacother. 2008. PMID: 18775388

6

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW. Dalal AA, et al. Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 21311689 Free PMC article.

7

Economic burden of chronic bronchitis in the United States: a retrospective case-control study.

Blanchette CM, Roberts MH, Petersen H, Dalal AA, Mapel DW. Blanchette CM, et al. Among authors: dalal aa. Int J Chron Obstruct Pulmon Dis. 2011 Jan 13;6:73-81. doi: 10.2147/COPD.S15882. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21311695 Free PMC article.

8

Changes in COPD demographics and costs over 20 years.

Blanchette CM, Dalal AA, Mapel D. Blanchette CM, et al. Among authors: dalal aa. J Med Econ. 2012;15(6):1176-82. doi: 10.3111/13696998.2012.713880. Epub 2012 Aug 1. J Med Econ. 2012. PMID: 22812689 Free article.

9

Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.

Dalal AA, Petersen H, Simoni-Wastila L, Blanchette CM. Dalal AA, et al. J Med Econ. 2009;12(4):339-47. doi: 10.3111/13696990903369135. J Med Econ. 2009. PMID: 19827993 Free article.

10

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA. Simoni-Wastila L, et al. Among authors: dalal aa. Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003. Am J Geriatr Pharmacother. 2009. PMID: 19948302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page